Willingness of community-recruited men who have sex with men in Washington DC to use long-acting injectable HIV pre-exposure prophylaxis

摘要

ObjectivesClinical trials are currently investigating the safety and efficacy of long-acting injectable (LAI) agents as HIV pre-exposure prophylaxis (PrEP). Using National HIV Behavioral Surveillance data, we assessed the self-reported willingness of men who have sex with men (MSM) to use LAI PrEP and their preference for LAI versus daily oral PrEP.